Palmitoylethanolamide (PEA) is a member of the endocannabinoid fatty acid amides and exhibits potent anti-inflammatory and analgesic properties.* Extensive clinical evidence supports the pleiotropic effects of PEA, where it appears to exert it’s therapeutic effects via more than one mode of action, by modulating the endocannabinoid system in a safer and therapeutically efficacious manner.*
PEA is typically poorly water-soluble which affects oral absorption and bioavailability.* Micronization helps reduce large PEA particles to the micron range (<10 μm), providing a larger total surface area and enables rapid dissolution and therapeutic efficacy corroborated by preclinical evidence.*
Pain Relief SAP:
- Provides high quality micronized PEA for enhanced absorption, bioavailability, and efficacy.*
- Helps relieve joint pain associated with osteoarthritis.*
Ingredients
Serving Size: 2 Capsules
Servings Per Container: 60 |
| | Amount Per Serving | % Daily Value |
| Palmitoylethanolamide (micronized) | 600 mg | ** |
| Devil’s claw (Harpagophytum procumbens) extract, 5% harpagosides | 60 mg | ** |
| **Daily Value not established. |
Other ingredients: Microcrystalline cellulose, hypromellose, vegetable magnesium stearate, purified water, and silicon dioxide.
Contains no
Gluten, soy, wheat, eggs, dairy, yeast, citrus, preservatives, artificial flavor or color, starch, or sugar.
Directions for use
Adults: Take 2-4 capsules daily or as directed by your healthcare practitioner.
Duration for use
Use for a minimum of 2-3 months to see beneficial effects.
| * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
